搜索临床试验以:IDP-118 车用乳液
总计2748个结果
-
Beth Israel Deaconess Medical CenterJohns Hopkins University; Dana-Farber Cancer Institute; AstraZeneca主动,不招人转移性乳腺癌 | 浸润性乳腺癌 | BRIP1基因突变 | PALB2基因突变 | ATM基因突变 | CHEK2基因突变 | NBN基因突变 | RAD51基因突变 | 体细胞突变乳腺癌 (BRCA1) | 体细胞突变乳腺癌 (BRCA2)美国
-
AstraZenecaKuDOS Pharmaceuticals Limited完全的
-
Brown UniversityAstraZeneca; The Miriam Hospital; Rhode Island Hospital终止
-
Royal Marsden NHS Foundation TrustAstraZeneca; Institute of Cancer Research, United Kingdom完全的
-
Paul Mathew, MDHoosier Cancer Research Network; Tesaro, Inc.终止
-
PfizerMedivation, Inc.完全的急性髓性白血病 | 套细胞淋巴瘤 | 慢性淋巴细胞白血病 | 骨髓增生异常综合症英国, 美国
-
Institut National de la Santé Et de la Recherche...未知多发性硬化症 | 复发缓解型多发性硬化症
-
Korea University Anam HospitalTakeda; Korean Cancer Study Group尚未招聘
-
Assistance Publique - Hôpitaux de Paris尚未招聘Metastatic Breast Cancer in Germline-PALB2 Mutations Carriers
-
National University Hospital, Singapore招聘中
-
Institute of Cancer Research, United KingdomAstraZeneca; Cancer Research UK招聘中
-
Mario Negri Institute for Pharmacological ResearchNorth Eastern German Society of Gynaecological Oncology主动,不招人
-
Matthew GalskyIcahn School of Medicine at Mount Sinai; AstraZeneca完全的
-
AstraZeneca完全的
-
UNICANCERClovis Oncology, Inc.; Fondation ARC完全的
-
Dana-Farber Cancer Institute撤销
-
Sanofi完全的
-
Ocuphire Pharma, Inc.Ophthalmic Consultants of Long Island完全的
-
GlaxoSmithKline完全的
-
Stiefel, a GSK CompanyGlaxoSmithKline; Quintiles, Inc.; Rho, Inc.完全的
-
Nanfang Hospital of Southern Medical UniversityNovartis; Major Science and Technology Special Project of China Eleventh Five-year完全的
-
Sunnybrook Health Sciences CentreCanadian Institutes of Health Research (CIHR)招聘中
-
Zhejiang Cancer HospitalJiangsu Hengrui Pharmaceutical Co., Ltd.尚未招聘女性乳腺癌患者 | 组织病理学证实的晚期 HR +/HER2 浸润性乳腺癌 | HRD 阳性晚期乳腺癌